بدائل البحث:
significant potential » significant positive (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), marked decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
potential group » potential drug (توسيع البحث), potential cross (توسيع البحث), potential from (توسيع البحث)
significant potential » significant positive (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), marked decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
potential group » potential drug (توسيع البحث), potential cross (توسيع البحث), potential from (توسيع البحث)
-
101
-
102
-
103
-
104
-
105
-
106
-
107
Scheme of g-λ model with larger values λ.
منشور في 2024"…The findings suggest that when λ is respectively equal to 4.19, 8.57, 10, and 12.15, the peak particle velocity (PPV) of the transmitted waves is significantly close to the incident wave amplitude. Furthermore, when λ is fixed, the energy transmission coefficient increases with the incident wave amplitude but decreases with the incident wave frequency. …"
-
108
-
109
-
110
-
111
Gallbladder fossa parameters in livers with gallbladders, segregated by sex.
منشور في 2021الموضوعات: -
112
-
113
-
114
-
115
-
116
Comparison of gallbladder fossa parameters in livers from cadavers with and without gallbladders.
منشور في 2021الموضوعات: -
117
-
118
Study Data.
منشور في 2025"…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
-
119
Study outcomes.
منشور في 2025"…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
-
120
Patient characteristics.
منشور في 2025"…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"